Howard Robin

Howard Robin

Amministratore Delegato presso NEKTAR THERAPEUTICS

Patrimonio netto: 4 M $ in data 30/06/2026

73 anni
Health Technology
Commercial Services
Consumer Services

Profilo

Howard W.
Robin
is President, Chief Executive Officer & Director at Nektar Therapeutics since 2007.
Formerly, Mr. Robin was President, Chief Executive Officer & Director at Sirna Therapeutics, Inc. from 2001 to 2006.
From 1984 to 2001, held roles at Berlex, Inc., including Director-Business Planning & Development from 1987 to 2001 and Vice President & General Manager from 1991 to 2001.
Also served as Director at Acologix, Inc., Biotechnology Innovation Organization, and The Bay Area Bioscience Association.
Worked as Senior Associate at Arthur Andersen LLP.
Served as Trustee at Fairleigh Dickinson University.
Education includes an undergraduate degree from Fairleigh Dickinson University, conferred in 1974.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValutazioneData di valutazione
17/06/2026 55.073 ( 0,16% ) 4 M $ 30/06/2026

Posizioni attive di Howard Robin

SocietàPosizioneInizio
NEKTAR THERAPEUTICS Amministratore Delegato 01/01/2007

Precedenti posizioni note di Howard Robin

SocietàPosizioneFine
Amministratore Delegato 01/11/2006
Corporate Officer/Principal -
Berlex Laboratories, Inc.
Direttore Finanziario/CFO 01/01/1991
Direttore/Membro del Consiglio -
Direttore/Membro del Consiglio -
Vedi nel dettaglio l'esperienza di Howard Robin

Formazione di Howard Robin

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

70

Relazioni di 1° grado

9

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private9

Health Technology

Commercial Services

Health Technology

Health Technology

Commercial Services

Commercial Services

Consumer Services

Health Technology

Berlex Laboratories, Inc.

  1. Mercati
  2. Insiders
  3. Howard Robin